phase readout
saveNCT05366218: Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
RECRUITINGupdated 6m ago
community read0 votes
Sponsor: University Hospital Tuebingen. Phase: PHASE1. Conditions: ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory
view source ↗
comments(0)
5-min edit window · permanent after that